CD22 deficiency alters B cell populations and plasma triglyceride levels but does not affect atherosclerosis in hyperlipidemic mice

被引：0
|
作者：
Porsch, F. [1 ]
Kiss, M. [1 ]
Tsiantoulas, D. [1 ]
Goederle, L. [1 ]
Ozsvar-Kozma, M. [1 ]
Binder, C. J. [1 ]
机构：
[1] Med Univ Vienna, Dept Lab Med, Vienna, Austria
来源：
CARDIOVASCULAR RESEARCH | 2018年 / 114卷
基金：
奥地利科学基金会;
关键词：
D O I：
10.1093/cvr/cvy060.288
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P379
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 33 条
  • [1] CD22 DEFICIENCY REDUCES PLASMA TRIGLYCERIDE LEVELS WITHOUT AFFECTING ATHEROSCLEROTIC LESION SIZE IN FEMALE LDLR-/- MICE
    Porsch, F. S.
    Kiss, M.
    Tsiantoulas, D.
    Ozsvar-Kozma, M.
    Goederle, L.
    Nitschke, L.
    Binder, C. J.
    ATHEROSCLEROSIS, 2018, 275 : E44 - E45
  • [2] GLOBAL AND HAEMATOPOIETIC CD22 DEFICIENCY IN LDLR-/- MICE REDUCE PLASMA TRIGLYCERIDE AND CHOLESTEROL LEVELS WITHOUT AFFECTING LESION FORMATION
    Porsch, F.
    Kiss, M.
    Tsiantoulas, D.
    Goederle, L.
    Ozsvar-Kozma, M.
    Nitschke, L.
    Mallat, Z.
    Binder, C. J.
    ATHEROSCLEROSIS, 2019, 287 : E23 - E23
  • [3] CD22 deficiency influences the incidence of B cell lymphoma
    Inaoki, M
    Sato, S
    Hasegawa, M
    Tedder, TF
    Takehara, K
    FASEB JOURNAL, 2003, 17 (07) : C324 - C324
  • [4] Deficiency in sPLA2 does not affect HDL levels or atherosclerosis in mice
    Burton, CA
    Patel, S
    Mundt, S
    Hassing, H
    Zhang, DH
    Hermanowski-Vosatka, A
    Wright, SD
    Chao, YS
    Detmers, PA
    Sparrow, CP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (01) : 88 - 94
  • [5] IN VIVO EFFECTS OF EPRATUZUMAB, A MONOCLONAL ANTIBODY TARGETING HUMAN CD22, ON B CELL FUNCTION IN HUMAN CD22 KNOCK-IN (HUKI) MICE
    Brandl, C.
    Oezgoer, L.
    Woehner, M.
    Shock, A.
    Nitschke, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 811 - 811
  • [6] In Vivo Effects of Epratuzumab, a Monoclonal Antibody Targeting Human CD22, on B Cell Function in Human CD22 Knock-in (Huki) Mice
    Brandl, Carolin
    Oezgoer, Lamia
    Woehner, Miriam
    Shock, Anthony
    Nitschke, Lars
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S855 - S856
  • [7] B cell signaling pathways in CD22, ST6Gal I and CD22/ST6Gal I null mice
    Collins, BE
    Bengtson, P
    Nitschke, L
    Marth, JD
    Paulson, JC
    GLYCOBIOLOGY, 2004, 14 (11) : 1140 - 1140
  • [8] Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling
    Brian E Collins
    Brian A Smith
    Per Bengtson
    James C Paulson
    Nature Immunology, 2006, 7 : 199 - 206
  • [9] Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling
    Collins, BE
    Smith, BA
    Bengtson, P
    Paulson, JC
    NATURE IMMUNOLOGY, 2006, 7 (02) : 199 - 206
  • [10] Inhibition of B Cell Activation and Plasma Cell Differentiation By Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22
    Giltiay, Natalia V.
    Shu, Geraldine L.
    Shock, Anthony
    Clark, Edward A.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
1234